Program Overview

Johnson & Johnson Pvt. Limited is committed to helping patients access necessary cancer treatments through its Patient Assistance Programs. This initiative is designed to support individuals in need of Imbruvica 140mg capsules, offering more affordable options for eligible patients with qualifying medical conditions.

Program Benefits of Imbruvica 140mg

The Patient Assistance Program covers conditions such as Chronic Lymphoid Leukemia (CLL) and NCL. Under this program, when you purchase one bottle of Imbruvica, you receive an additional bottle free. For the latest updates on Imbruvica, patients are encouraged to contact our support team.

Eligibility for Imbruvica Program

To enroll in Johnson & Johnson’s Patient Assistance Program for Imbruvica, patients must:

• Have a valid prescription for Ibrutinib 140mg from a certified medical oncologist

• Be an Indian citizen with a valid identity document

• Meet specific condition- and program-based eligibility requirements

Contact Information for Imbruvica Assistance

For questions or help with the application process for Imbruvica, reach out to our dedicated team:

• Email: info@zyloxd.com

Note: Zyloxd is not affiliated with the PAP program. However, we offer free consultations to help patients understand available Imbruvica Patient Assistance Programs. Eligible patients can apply directly without purchasing through Zyloxd.

Introduction to Imbruvica Capsule

Imbruvica Capsule contains the active ingredient Ibrutinib, a targeted therapy used in the treatment of various blood cancers:

• Mantle Cell Lymphoma (MCL)

• Chronic Lymphocytic Leukaemia (CLL)

• Small Lymphocytic Lymphoma (SLL)

• Waldenstrom’s Macroglobulinemia

• Marginal Zone Lymphoma (MZL)

• Chronic Graft Versus Host Disease (cGvHD)

Imbruvica inhibits cancer growth by blocking Bruton’s tyrosine kinase (BTK), reducing tumor spread, and improving patient survival outcomes.

Uses of Imbruvica Capsule

• Treatment of Mantle Cell Lymphoma

• Chronic Lymphocytic Leukaemia

• Small Lymphocytic Lymphoma

• Waldenstrom’s Macroglobulinemia

• Chronic Graft vs. Host Disease after systemic therapy failure

Therapeutic Effects of Imbruvica

As a BTK inhibitor, Imbruvica disrupts cancer cell signaling, promoting cell death and limiting tumor development. Its oral dosage form offers a less invasive option compared to chemotherapy.

Drug Interactions with Imbruvica

Imbruvica is metabolized via CYP3A enzymes. Key interactions include:

• Inhibitors: (e.g., ketoconazole, clarithromycin) – may increase toxicity

• Inducers: (e.g., rifampin, carbamazepine) – may reduce efficacy

• Avoid grapefruit and Seville oranges

How to Take Imbruvica 140mg

• Take Imbruvica 140mg at the same time each day

• Swallow whole; do not chew or crush

• Avoid citrus (grapefruit/oranges)

• Stay hydrated

Safety Advice for Imbruvica 140mg

• Pregnancy: Unsafe – use contraception during and for 1 month after treatment

• Breastfeeding: Not recommended

• Liver/Lung Issues: Consult a doctor

• Driving: Avoid if dizziness or fatigue occurs

Side Effects of Imbruvica 140mg

Common:

• Nausea

• Diarrhea

• Rash

• Bruising

• Muscle pain

• Fatigue

Serious:

• Bleeding

• Infections

• Cardiac issues

• Severe allergic reactions

• Secondary cancers

Word of Advice on Imbruvica 140mg

Notify your doctor if you experience symptoms like chest pain, infection, or liver problems. Imbruvica 140mg should not be used before/after surgery due to delayed wound healing. Use contraception during and after the final dose.

FAQs About Imbruvica 140mg

Q1. Can Imbruvica 140mg prevent cancer?
No. It treats specific blood cancers but does not prevent them.

Q2. Can I take Imbruvica 140mg with other drugs?
It interacts with many medications. Inform your doctor of all current prescriptions.

Q3. How long should I take Imbruvica 140mg?
Duration depends on your condition and doctor’s guidance.

Q4. Can I drink alcohol while on Imbruvica 140mg?
Not advised, as it may strain liver function.

Q5. Does Imbruvica 140mg cure all cancers?
No, it is effective for specific types of blood cancers only.

Q6. Should I use contraception while on Imbruvica 140mg?
Yes, during treatment and for one month after your last dose.

Fact Box – Imbruvica 140mg Capsule

• Molecule: Ibrutinib

• Class: BTK Inhibitor

• Therapeutic Use: Anti-neoplastic

• Indications: CLL, SLL, WM, MCL, cGvHD

References

• EMC

• FDA Prescribing Information PDF

• PubMed Study

• FDA Drug Approval Application

Disclaimer

The information provided is for educational purposes only and does not substitute for professional medical advice. Always consult your healthcare provider before starting or modifying any treatment involving Imbruvica 140mg.